FDA label
What is Prevymis used for?
Prevymis contains letermovir. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label for Prevymis lists 2 uses: CMV Prophylaxis in Hematopoietic Stem Cell Transplant (HSCT) Recipients; CMV Prophylaxis in Kidney Transplant Recipients.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Prevymis?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Prevymis, tablet, film coated
Indications and Usage, quoted from the label by Merck Sharp & Dohme LLC (NDA209939). Cross-references to other label sections are left out.
CMV Prophylaxis in Hematopoietic Stem Cell Transplant (HSCT) Recipients
PREVYMIS® is indicated for prophylaxis of cytomegalovirus (CMV) infection and disease in adult and pediatric patients 6 months of age and older and weighing at least 6 kg who are CMV-seropositive recipients [R+] of an allogeneic hematopoietic stem cell transplant (HSCT).
CMV Prophylaxis in Kidney Transplant Recipients
PREVYMIS is indicated for prophylaxis of CMV disease in adult and pediatric patients 12 years of age and older and weighing at least 40 kg who are kidney transplant recipients at high risk (Donor CMV seropositive/Recipient CMV seronegative [D+/R-]).
Source: DailyMed label, set id 1b49df80-be4f-47e0-a0b7-123f3e69395b, version 28, effective January 14, 2026. NDC 0006-3075, one of 2 listings for this product.
Questions
What is Prevymis used for?
The FDA label for Prevymis lists 2 uses: CMV Prophylaxis in Hematopoietic Stem Cell Transplant (HSCT) Recipients; CMV Prophylaxis in Kidney Transplant Recipients.
What drug class is Prevymis?
FDA lists letermovir in the Cytomegalovirus DNA Terminase Complex Inhibitor established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.